What are dexloxiglumide drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

dexloxiglumide drugs are pharmacologic agents that share a common mechanism (typically targeting Cholecystokinin receptor type A). 0 are currently marketed, with 2 more in clinical development.

dexloxiglumide

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all dexloxiglumide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cholecystokinin receptor type A, Cholecystokinin receptor type A, Cholecystokinin receptor type A.

Targets

Cholecystokinin receptor type A · Cholecystokinin receptor type A, Cholecystokinin receptor type A

Phase 3 pipeline (1)

D-Loxiglumide · Gastroenterology
Dexloxiglumide works by binding to the cholecystokinin receptor type A, which is involved in regulating digestive processes.

Phase 2 pipeline (1)

LOXIGLUMIDE · Gastroenterology
Loxiglumide works by binding to the cholecystokinin receptor type A, which helps to slow down gastric emptying and reduce symptoms of certain gastrointestinal disorders.

Patent intelligence

loxiglumide patent landscape — aggregated cliff calendar, attackable patents, originator estates